Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling-Reference-Cited by-同舟云学术

Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling

Published:2021-10 Issue: Volume:909 Page:174411
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Li Yanping,Xiao Xiaoqian,Wang Huili,Zhou Qi,Jin Zhao,Zhang Yuxi,Wang Yi,Yue Fuping,Zhou Shiyi,Yang Jiahui

Publisher

Elsevier BV

Subject

Pharmacology

Reference44 articles.

1. HIF-1 at the crossroads of hypoxia, inflammation, and cancer;Balamurugan;J.Int J Cancer.,2016

2. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis;Carmeliet;J,1998

3. Dihydroartemisinin prevents progression and metastasis of head and neck squamous cell carcinoma by inhibiting polarization of macrophages in tumor microenvironment;Chen;J.Onco Targets Ther.,2020

4. Macrophage HIF-1alpha is an independent prognostic indicator in kidney cancer;Cowman;J. Clin. Case Rep.,2020

5. Dihydroartemisinin sensitizes esophageal squamous cell carcinoma to Cisplatin by inhibiting sonic hedgehog signaling;Cui;J.Front Cell Dev Biol.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer;International Immunopharmacology;2024-05

2. Natural products targeting autophagy and apoptosis in NSCLC: a novel therapeutic strategy;Frontiers in Oncology;2024-04-02

3. Tumor-associated macrophages affect the treatment of lung cancer;Heliyon;2024-04

4. Potential Role of Artemisinin And Its Derivatives In The Treatment of Age-related Macular Degeneration;2022-09-08

5. Asiatic acid alleviates liver fibrosis via multiple signaling pathways based on integrated network pharmacology and lipidomics;European Journal of Pharmacology;2022-09